CD28 co-stimulatory domain enhances efficacy of CER T cell therapy compared to 4-1BB in an ovarian cancer mouse model

Related articles

1. Nanoparticle-mediated delivery of PD-L1 inhibitor enhances γδ T cell immunotherapy against metastatic ovarian cancer cells

   This article has 18 authors:

   1. Laura O’Conner
   2. Jessica Eakins
   3. Mark Bates
   4. Ola Ibrahim
   5. Cara Martin
   6. Victoria Malone
   7. Steven G. Gray
   8. Feras Abu Saadeh
   9. Hassan Rajab
   10. Doug A. Brooks
   11. Ciaran M. Maguire
   12. Stavros Selemidis
   13. Julie David
   14. Elena Matsa
   15. Sharon O’Toole
   16. John J. O’Leary
   17. Derek G. Doherty
   18. Bashir M. Mohamed

2. Tumor Microenvironmental Regulation of CAR T-Cell Therapy in High Risk Medulloblastoma

   This article has 19 authors:

   1. Dalia Haydar
   2. Serge Yaacoub
   3. Mostafa Seblani
   4. Kaleem Coleman
   5. Zhongzhen Yi
   6. Kyoungtea Kim
   7. Shang-Yang Chen
   8. Bicna Song
   9. Chao Di
   10. Leon McSwain
   11. Gage Paul
   12. Olga Rodriguez
   13. Christopher Albanese
   14. Alexander V. Kabanov
   15. Timothy Gershon
   16. Jo Lynne Rokita
   17. Christopher Lazarski
   18. Martine Roussel
   19. Marina Sokolsky-Papkov

3. Conventional dendritic cells type I with an enhanced type-I-IFN signaling underpin anti-tumor immune responses in brain metastases

   This article has 16 authors:

   1. Fiona James
   2. Alena Revalova
   3. Christopher Fife
   4. Jennifer Williams
   5. Dario Guglietta
   6. Zarnaz Hadi
   7. Elton J. R. Vasconcelos
   8. Ashley Sunderland
   9. Grace Mallett
   10. Nicola Ingram
   11. Tsuneyasu Kaisho
   12. William J. Brackenbury
   13. Merin Lawrence
   14. David R. Westhead
   15. Andrew S. MacDonald
   16. Mihaela Lorger